Volume 14, Issue 5, Pages (November 2013)

Slides:



Advertisements
Similar presentations
Smita Srivastava, Patricia S. Grace, Joel D. Ernst  Cell Host & Microbe 
Advertisements

Volume 13, Issue 5, Pages (May 2011)
Volume 36, Issue 3, Pages (March 2012)
Mechanism of Cross-Species Prion Transmission
Hans-Peter Raué, Carol Beadling, Jennifer Haun, Mark K. Slifka 
Volume 6, Issue 5, Pages e5 (May 2018)
Volume 165, Issue 7, Pages (June 2016)
Volume 12, Issue 4, Pages (October 2012)
Volume 8, Issue 6, Pages (December 2010)
Volume 37, Issue 5, Pages (March 2010)
Thrombopoietin responsiveness reflects the number of doublings undergone by megakaryocyte progenitors by Jean-Michel Paulus, Najet Debili, Frédéric Larbret,
Volume 18, Issue 3, Pages (September 2015)
Volume 102, Issue 10, Pages (May 2012)
Volume 20, Issue 12, Pages (September 2017)
Choice Certainty Is Informed by Both Evidence and Decision Time
Volume 38, Issue 2, Pages (February 2013)
Volume 10, Issue 6, Pages (December 2011)
Volume 16, Issue 5, Pages (November 2014)
Volume 18, Issue 12, Pages (December 2010)
Volume 23, Issue 4, Pages (April 2018)
Alice C.L. Len, Shimona Starling, Maitreyi Shivkumar, Clare Jolly 
HIV-1 Vpu Mediates HLA-C Downregulation
Volume 16, Issue 1, Pages (January 2002)
Volume 6, Issue 4, Pages (October 2009)
Volume 20, Issue 4, Pages (October 2016)
The Nogo Receptor NgR1 Mediates Infection by Mammalian Reovirus
Volume 23, Issue 10, Pages (October 2016)
Volume 22, Issue 3, Pages e5 (September 2017)
Volume 153, Issue 4, Pages (May 2013)
Jianing Yu, David Ferster  Neuron 
Volume 59, Issue 5, Pages (September 2015)
Lea Goentoro, Marc W. Kirschner  Molecular Cell 
Volume 16, Issue 3, Pages (September 2014)
Volume 1, Issue 2, Pages (April 2007)
Smita Srivastava, Patricia S. Grace, Joel D. Ernst  Cell Host & Microbe 
HIV-Host Interactions: Implications for Vaccine Design
Breaking the Barrier: Host Cell Invasion by Lujo Virus
Volume 54, Issue 5, Pages (June 2014)
Volume 39, Issue 3, Pages (August 2010)
Volume 19, Issue 3, Pages (March 2016)
Alexander Falkenhagen, Sadhna Joshi  Molecular Therapy - Nucleic Acids 
Adam S. Dingens, Hugh K. Haddox, Julie Overbaugh, Jesse D. Bloom 
Volume 14, Issue 5, Pages (November 2013)
Volume 15, Issue 2, Pages (February 2014)
Volume 10, Issue 3, Pages (September 2011)
Volume 110, Issue 1, Pages (January 2016)
Double Trouble: HIV Latency and CTL Escape
Volume 22, Issue 1, Pages e4 (July 2017)
Volume 23, Issue 3, Pages (April 2018)
Volume 6, Issue 1, Pages (July 2009)
Volume 16, Issue 12, Pages (June 2006)
Volume 1, Issue 3, Pages (May 2007)
Volume 16, Issue 6, Pages (December 2014)
Protein Misfolded Oligomers: Experimental Approaches, Mechanism of Formation, and Structure-Toxicity Relationships  Francesco Bemporad, Fabrizio Chiti 
May K. Wang, Sun-Young Lim, Soo Mi Lee, James M. Cunningham 
Volume 36, Issue 3, Pages (March 2012)
Volume 8, Issue 4, Pages (October 2010)
Infectious Entry and Neutralization of Pathogenic JC Polyomaviruses
Cellular 5′-3′ mRNA Exonuclease Xrn1 Controls Double-Stranded RNA Accumulation and Anti-Viral Responses  Hannah M. Burgess, Ian Mohr  Cell Host & Microbe 
Volume 13, Issue 5, Pages (May 2011)
Volume 9, Issue 1, Pages (January 2011)
A Stable Prefusion Intermediate of the Alphavirus Fusion Protein Reveals Critical Features of Class II Membrane Fusion  Claudia Sánchez-San Martín, Hernando.
Actin’ on HIV: How Dendritic Cells Spread Infection
Volume 16, Issue 11, Pages (November 2008)
HIV Broadly Neutralizing Antibodies: Taking Good Care Of The 98%
Positive and Negative Control of Enhancer-Promoter Interactions by Other DNA Loops Generates Specificity and Tunability  Nan Hao, Keith E. Shearwin, Ian.
Dissecting the Multifactorial Causes of Immunodominance in Class I–Restricted T Cell Responses to Viruses  Weisan Chen, Luis C. Antón, Jack R. Bennink,
Volume 114, Issue 2, Pages (July 2003)
Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner  Juan Lama, Aram Mangasarian,
HIV and Chemokine Binding to Red Blood Cells—DARC Matters
Presentation transcript:

Volume 14, Issue 5, Pages 547-558 (November 2013) Modeling Virus- and Antibody-Specific Factors to Predict Human Immunodeficiency Virus Neutralization Efficiency  Hillel Haim, Ignacio Salas, Kathleen McGee, Noah Eichelberger, Elizabeth Winter, Beatriz Pacheco, Joseph Sodroski  Cell Host & Microbe  Volume 14, Issue 5, Pages 547-558 (November 2013) DOI: 10.1016/j.chom.2013.10.006 Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 1 Ab Interaction with Primary HIV-1 Env Trimers (A and B) Correlation between binding of monoclonal Abs and CD4-Ig (at 2 μg/ml) to the cell surface Envs of the AD8 (A) and JRFL (B) HIV-1 strains and the reciprocal of the Ab concentration (in μg/ml) required for half-maximal inhibition of the infection of viruses with the same Envs. Binding of each Ab is expressed as a fraction of the binding of the 2G12 Ab (at 2 μg/ml) to Env. (C) Sampling frequency of the Env conformations competent for binding the indicated monoclonal Abs and CD4-Ig. Error bars = SEM. (D) Effect of sCD4 binding (15 μg/ml) on the AD8 Env sampling frequency associated with the indicated Abs. For the absolute binding values, see Figure S1C. (E) Correlation between the PF values measured for each Ab on the AD8 and JRFL Envs. The 48d Ab is excluded from this correlation due to the low binding values for the JRFL Env. The symbols are color coded based on PF (blue, low; red, high). Spearman rank-order correlation coefficient, rS; p value, two-tailed t test. (F) PF values for the panel of Abs measured on the AD8 and three clade C HIV-1 Envs. Asterisks represent sampling frequencies that could not be calculated due to undetectable Ab binding to that Env. (G) Spearman rank-order coefficients for correlations between PF values of the Ab panel, measured on clade B and C HIV-1 Envs. p values are indicated in parentheses, and the boxes are color coded according to the strength of the correlation. Data are represented as mean ± SEM. Figure 1 is related to Figure S1. Cell Host & Microbe 2013 14, 547-558DOI: (10.1016/j.chom.2013.10.006) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 2 Relationship between the Perturbation Factor and Ab On-Rate, Binding Efficiency, and Neutralization Potency (A and B) Inverse correlation between the PF associated with each Ab and either the on-rate of the Ab (A) or the binding efficiency of the Ab (B) to AD8 Env. (C and D) Correlation between either the Ab PF (C) or the Ab binding efficiency (D) measured on the AD8 and JRFL Envs and Ab neutralization of virus containing these Envs. The AD8 (black-bordered symbols) and JRFL (red-bordered symbols) data are pooled. Data points are colored according to PF. Spearman rank-order correlation coefficient, rS; p value, two-tailed t test. Cell Host & Microbe 2013 14, 547-558DOI: (10.1016/j.chom.2013.10.006) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 3 Ab-Env Binding, PF and Neutralization of AD8 Variants that Differ in Env Reactivity (A) Relationship between Ab binding and inhibition of two AD8 Env variants that differ in the level of ER. Light blue lines are drawn between data points representing the same Ab tested with the two Envs. Abs with an IC50 value greater than 20 μg/ml were assigned a neutralization value of 0.05. (B) Fold increase in neutralization sensitivity (1/IC50) of J3Hx(197,HT,N) relative to J3Hx(197) for the indicated Abs and CD4-Ig. The colors of the bars indicate the PF values of the Abs, measured on the AD8 Env. (C and D) Correlations between either the Ab binding efficiency (C) or the Ab PF (D) measured on the J3Hx(197) Env and the fold increase in neutralizing potency (1/IC50) for J3Hx(197,HT,N) relative to J3HX(197). Spearman rank-order correlation coefficient, rS; p value, two-tailed t test. Cell Host & Microbe 2013 14, 547-558DOI: (10.1016/j.chom.2013.10.006) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 4 Ab-Env Binding, PF, and Neutralization of HXBc2 Variants with Different ER Values (A) Relationship between Ab binding and inhibition of the high-ER HXBc2 Env and the low-ER HXBc2(ΔQR) Env. Abs that had a measured IC50 value greater than 30 μg/ml were assigned a neutralization value of 0.03. (B) Fold increase in neutralization sensitivity (1/IC50) of virus containing the HXBc2 Env relative to the HXBc2(ΔQR) Env for the indicated Abs and CD4-Ig. The colors of the bars indicate the PF values of the Abs, measured on the AD8 Env. (C) Correlation between the effects of ER on inhibition by each Ab for the J3Hx(197,HT,N)-J3Hx(197) pair and the HXBc2-HXBc2(ΔQR) pair. (D) Correlation between the PF values measured on the AD8 and HXBc2(ΔQR) Envs. (E) Correlation between PF of Abs measured on the AD8 Env and fold increase in neutralizing potency (1/IC50) for HXBc2(ΔQR). Abs are colored according to PF values, measured on the AD8 Env. Spearman rank-order correlation coefficient, rS; p value, two-tailed t test. Figure 4 is related to Figure S2. Cell Host & Microbe 2013 14, 547-558DOI: (10.1016/j.chom.2013.10.006) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 5 Explanatory Capability of Different Models of HIV-1 Neutralization (A) Correlations between the measured relative neutralization sensitivity of HXBc2 and HXBc2(ΔQR) viruses and the relative neutralization sensitivity predicted by a model based on Equation 2 (top panel) or a model based only on Ab-Env binding (bottom panel). (B) Correlations between predicted and measured levels of inhibition. Nine closely matched variants of the AD8 Env that differ in ER were tested for their sensitivity to each of the indicated Abs. For each Ab, we show the correlation between the measured neutralization sensitivity and the neutralization sensitivity predicted by models based on Ab-Env binding alone, ER alone, or the multiple parameters in Equation 2. Spearman rank-order correlation coefficients are reported and are colored according to the strength of the correlation, as detailed in the key. (C) Correlations between the measured neutralization sensitivity of the nine AD8 variants to the low-PF Abs (upper row), the high-PF Abs (middle row), and all Abs (lower row) and the neutralization sensitivity predicted by a model based on Ab-Env binding alone (left panels) or based on Equation 2 (right panels). To allow a quantitative comparison of the neutralization obtained with different Abs, all data for each Env variant are expressed as the fold change in the measured or calculated value relative to the value obtained for the AD8 Env, which is assigned a value of 1. Spearman rank-order correlation coefficient, rS; p value, two-tailed t test. The PF values of the Abs used for the calculations in this figure were measured on the AD8 Env. Cell Host & Microbe 2013 14, 547-558DOI: (10.1016/j.chom.2013.10.006) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 6 Reversibility of Ab-Env Binding and HIV-1 Inhibition (A) Sensitivity of viruses containing the indicated Env to neutralization by the given Abs was measured, and the concentration required for neutralization of 90% of free virus (i.e., virus in suspension) was determined. (B) Viruses containing the indicated Envs were bound to protein-binding plates and incubated with the Abs at a concentration that neutralizes 90% of free virus. Cf2Th CD4+CCR5+ target cells were then added to the viruses either in the presence of Ab or after washing the virus extensively. The virus-cell mixture was then incubated at 37°C for 1 hr to allow entry, after which cells were trypsinized to halt entry and further cultured for 2 days. Infectivity was measured by luciferase activity. For the absolute infection values, see Figure S3. The reversibility of inhibition was calculated by dividing the infectivity of washed virus by the infectivity of unwashed virus. Data are represented as mean ± SEM. (C) Correlation between the reversibility of inhibition of the J3Hx(197,HT,N) virus (corrected for the reversibility of Ab-Env binding) and the PF measured on the AD8 Env. Spearman rank-order correlation coefficient, rS; p value, two-tailed t test. Figure 6 is related to Figure S3. Cell Host & Microbe 2013 14, 547-558DOI: (10.1016/j.chom.2013.10.006) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 7 Model of HIV-1 Neutralization by Abs The efficiency of HIV-1 neutralization is determined by the capacity of the Ab to engage Env and to modulate its conformation. The metastable HIV-1 Env is maintained in a high-potential-energy state by activation energy barriers. The magnitude of these activation barriers determines the degree of Env reactivity (ER), which is defined as the propensity of Env to transition to lower-energy states upon perturbation. The sampling frequency of the Env conformations capable of binding each Ab reflects the degree of structural change (perturbation) required to achieve these conformations from the basal state of unliganded Env. Abs with low perturbation factors (PF; colored blue and green) recognize lower-energy (highly sampled) conformations and inhibit infection by reversibly preventing transitions down the productive (entry) pathway. Such low-PF Abs are less affected by the level of ER because little conformational perturbation of Env is required for binding. Inhibition by high-PF Abs (colored orange and red) is primarily determined by the level of ER because inhibition is mainly effected by promoting irreversible transitions down nonproductive pathways. Cell Host & Microbe 2013 14, 547-558DOI: (10.1016/j.chom.2013.10.006) Copyright © 2013 Elsevier Inc. Terms and Conditions